Abbott (ABT) Up 7.7% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/18/22
24-Month Data from Surmodics' TRANSCEND Trial Presented at VIVA 2022 ConferenceBusiness Wire • 11/02/22
ABT FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABTPRNewsWire • 10/31/22
ABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming DeadlineNewsfile Corp • 10/31/22
7 ‘Strong Buy' Dividend Aristocrats That Blew Away Q3 Earnings Expectations24/7 Wall Street • 10/31/22
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Abbott Investors of a Lead Plaintiff Deadline of October 31, 2022PRNewsWire • 10/31/22
Abbott Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 31, 2022 to Discuss Your Rights - ABTNewsfile Corp • 10/30/22
Abbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien FoundationPRNewsWire • 10/28/22
ABT SHAREHOLDER ALERT: Jakubowitz Law Reminds Abbott Shareholders of a Lead Plaintiff Deadline of October 31, 2022PRNewsWire • 10/28/22